Riskpilot← Back to searchSign inGet full accessCapero Medical AB
ABActiveOrg 5567227094Furugatan 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20070 employees
Revenue 2025
SEK 5M
+1% vs 2024
EBITDA margin
-1.2%
-168% vs 2024
Equity ratio
77.1%
Financial strength
Net profit 2025
SEK 32K
+78% vs 2024
| Revenue | SEK 5M | +1% |
| EBITDA | SEK -59K | -168% |
| Net profit | SEK 32K | +78% |
| Total assets | SEK 3,2M | -6% |
| Equity | SEK 2,5M | -13% |
| Employees | 0 | — |
Legal name
Capero Medical AB
Org number
5567227094
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 februari 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva handel med sjukvårdsprodukter och därmed förenlig verksamhet, konsultverksamhet inom sjukvård och fastighet samt idka handel med värdepapper.
Address
Furugatan 14
Phone
+46733414213
Email
info@capero.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 292 | 4 339 | 4 510 | 4 898 | 4 970 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 245 | 148 | 67 | −22 | −59 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 245 | 148 | 67 | −22 | −59 |
| Net financials | — | — | — | 3 | 58 |
| Profit before tax | 269 | 207 | 67 | 26 | 44 |
| Tax | −60 | −45 | −15 | −8 | −12 |
| Net profit | 209 | 162 | 52 | 18 | 32 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 841 | 3 925 | 3 686 | 3 441 | 3 225 |
| Equity | 2 825 | 2 986 | 3 038 | 2 856 | 2 488 |
| Long-term debt | 0 | 0 | 0 | 11 | 0 |
| Short-term debt | 730 | 710 | 419 | 391 | 597 |
| Total debt | 730 | 710 | 419 | 402 | 597 |
EBITDA margin
-1.2%
This company
15.8%
Market median
-108% vs market
20212025
Equity ratio
77.1%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20212025
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20212025
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF | Audit | 2022 |
IC Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AF | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Capero Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Henriksson | Audit | 0 companies |
| Anders Filip Lundberg | Audit | 0 companies |
| Ingela Carina Petersson | Chief Executive Officer | 0 companies |
| S Barbro I Sellmann Jansson | Deputy Board Member | 0 companies |